Enjoy this on-demand NephU webinar where we are joined by experts, Carl Bates, MD and Rannar Airik, PhD who will describe nephronophthisis (NPHP), the most frequent genetic cause for end-stage… Read More
Many advancements and innovations were made in the effort to improvement outcomes for kidney disease patients, this article reviews some of the most notable events. Read More
Genomics is beginning to have quite the impact in nephrology both regionally and globally. Learn more about this in this highly informative 2-part series! Read More
Genomics is beginning to have quite the impact in nephrology both regionally and globally. Learn more about this in this highly informative 2-part series! Read More
A recently announced program by the American Kidney Fund (AKF) promotes the awareness Fabry Disease. Read further to learn more about important details and symptoms of this rare disease. Read More
This presentation will discuss the pathophysiology, disease progression, and the physical & emotional burden of autosomal dominant polycystic kidney disease (ADPKD). The key factors that play into ADPKD disease diagnosis… Read More
NephU is supported by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) and Otsuka America Pharmaceutical, Inc. (OAPI) - committed supporters of the Kidney Health Community. The information provided through NephU is intended for the educational benefit of health care professionals and others who support care for those with kidney disease and other related conditions. It is not intended as, nor is it a substitute for, medical care, advice, or professional diagnosis. Health care professionals should use their independent medical judgement when reviewing NephU’s educational resources. Users seeking medical advice should consult with a health care professional. No CME or CEU credits are available through any of the resources provided by NephU. Some of the contributors may be paid consultants of OPDC and/or OAPI.